Peptide Receptor Radionuclide Therapy in Thyroid Cancer is a research paper published in Frontiers in Endocrinology (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
MeSH Terms
Keywords
Additional file 1 of Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs
Additional file 1 of Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs